Android app on Google Play

UBS Downgrades Par Pharmaceutical (PRX) to Neutral

August 8, 2012 7:13 AM EDT Send to a Friend
Get Alerts PRX Hot Sheet
Price: $49.98 --0%

Rating Summary:
    2 Buy, 8 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 20 | Down: 27 | New: 8
Trade PRX Now!
Join SI Premium – FREE
UBS downgraded Par Pharmaceutical (NYSE: PRX) from Buy to Neutral.

For an analyst ratings summary and ratings history on Par Pharmaceutical click here. For more ratings news on Par Pharmaceutical click here.

Shares of Par Pharmaceutical closed at $50.02 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

UBS

Add Your Comment